NM_002458.3:c.16960G>C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002458.3(MUC5B):c.16960G>C(p.Glu5654Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,612,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002458.3 missense
Scores
Clinical Significance
Conservation
Publications
- interstitial lung diseaseInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002458.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MUC5B | NM_002458.3 | MANE Select | c.16960G>C | p.Glu5654Gln | missense | Exon 47 of 49 | NP_002449.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MUC5B | ENST00000529681.5 | TSL:5 MANE Select | c.16960G>C | p.Glu5654Gln | missense | Exon 47 of 49 | ENSP00000436812.1 | ||
| MUC5B | ENST00000526859.1 | TSL:3 | c.435+545G>C | intron | N/A | ENSP00000434539.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152192Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000243 AC: 6AN: 246726 AF XY: 0.0000223 show subpopulations
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1460246Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 726398 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74352 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:2
Variant classified as Uncertain Significance - Favor Benign. The p.Glu5654Gln va riant in MUC5B has not been previously reported in individuals with cardiomyopat hy, but has been identified in 4/63298 European chromosomes by the Exome Aggrega tion Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs375272740). Gluta mic acid (Glu) at position 5654 is not conserved in mammals or evolutionarily di stant species and 2 mammals (hedgehog and wallaby) carry a glutamine (Gln) at th is position, raising the possibility that this change may be tolerated. Addition al computational prediction tools support that the p.Glu5654Gln variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the p.Glu5654Gln variant is uncertain, these data suggest that it is more likely to be benign.
The c.16960G>C (p.E5654Q) alteration is located in exon 47 (coding exon 47) of the MUC5B gene. This alteration results from a G to C substitution at nucleotide position 16960, causing the glutamic acid (E) at amino acid position 5654 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at